Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

First patient dosed in Novan's phase Ib study of SB-414 in atopic dermatitis

Dec. 7, 2017

Novel ex vivo cell and gene therapy regenerates entire human epidermis in patient with JEB

Dec. 7, 2017

Tioga reports reduced nighttime itching in asimadoline study in atopic dermatitis

Dec. 5, 2017

Impoyz approved in U.S. for plaque psoriasis

Dec. 4, 2017

EMA gives orphan drug designation to ProQR Therapeutics' QR-313

Nov. 30, 2017

European Commission approves Tremfya

Nov. 23, 2017

Menlo Therapeutics begins enrollment in PSORIXA study of serlopitant

Nov. 22, 2017

Bristol-Myers Squibb commences phase I/II trial of BMS-986251 for psoriasis

Nov. 20, 2017

Phase II study of topical radezolid for acne begins

Nov. 15, 2017

Devonian Health Group begins phase IIa study of Thykamine in atopic dermatitis

Nov. 13, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...